A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer
Phase 2
215
about 5.1 years
18+
Male only
7 sites in NJ, NY
What this study is about
This trial is testing whether stereotactic body radiation therapy (SBRT) without androgen deprivation therapy (ADT) can prevent prostate cancer from coming back or spreading. The researchers will also examine how safe and effective it is to use Decipher test results to determine which patients need more extensive radiation treatments.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Stereotactic Body Radiation Therapy (SBRT)
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Rate of biochemical progression free survival
Oncology